EUVIMEDEUVIMED entdecken
VergleichsstudieMetaanalyseSystematische Übersicht

Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression

Muhammad Tahir, Marium Ali Meghani, Muhammad Salik Uddin, Abbeha Talib iD, Zainab Binte Ahmad, Ammaar Ali Khan, Muhammad Ahmed iD, Lydia Dinsmore, Abdul Nasser, Raheel Ahmed, Abdul Basit, Taimor Mohammed Khan iD

Diabetes, Obesity and Metabolism · 2026-06 · 28 (6) · 4901-4914

DOI: 10.1111/dom.70676 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 23.03.2026. Verfasst von Muhammad Tahir und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan. Hauptthemen laut MEDLINE: Bariatric Surgery, Glucagon-Like Peptide-1 Receptor Agonists, Obesity, Weight Loss. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The comparative effectiveness of bariatric surgery (BS) and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for weight loss among patients with obesity remains uncertain.

Methods

MEDLINE, EMBASE and CENTRAL were searched to 5 October 2025. Pooled mean differences (MDs) for change in weight, body mass index (BMI), glycaemic indices, lipid profile and blood pressure were calculated using random‐effects models with heterogeneity quantified by I 2 . Outcomes were assessed separately according to time duration. Meta‐regression was performed for the primary outcome of change in BMI.

Results

Fifteen studies (20 594 participants) were included. Weight loss did not differ significantly at 6 months (MD –12.19 kg; p = 0.13), but favoured BS at ≤ 1 year (MD −16.97 kg; p = 0.02) and > 1 year (MD −19.78 kg; p < 0.001). BMI reduction consistently favoured BS at 6 months (MD −6.77 kg/m 2 ; p = 0.02), ≤ 1 year (MD −5.10 kg/m 2 ; p < 0.001) and > 1 year (MD −6.61 kg/m 2 ; p < 0.001). HbA1c reduction was greater with BS beyond one year (MD −1.69%; p < 0.001), and fasting glucose was lower overall with BS (MD −1.22 mmol/L; p = 0.03). Serum lipids and blood pressure showed no significant between‐group differences. Meta‐regression demonstrated larger BMI reductions with BS in older patients, male patients and those with higher baseline BMI.

Conclusion

Although substantial heterogeneity was present, BS was associated with greater and sustained reductions observed over multi‐year follow up in weight, BMI and glycaemic indices compared to GLP‐1 RAs, with similar effects on serum lipids and blood pressure, supporting its use in appropriately selected adults with obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryGlucagon-Like Peptide-1 Receptor AgonistsObesityWeight LossAdultHumansBody Mass IndexTreatment Outcome

Stichwörter der Autor:innen

BMI reductionGLP‐1 RAbariatric surgeryobesityweight loss

Substanzen

Glucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan.
  • Northern Hospital, Melbourne, Australia.
  • Sunderland Royal Hospital, Sunderland, UK.
  • Newcastle University, Newcastle upon Tyne, UK.
  • Indus Hospital and Health Network, Karachi, Pakistan.

ORCID-Profile: Abbeha Talib, Muhammad Ahmed, Taimor Mohammed Khan

Zitieren

APA

Tahir, M., Meghani, M. A., Uddin, M. S., Talib, A., Ahmad, Z. B., Khan, A. A., Ahmed, M., Dinsmore, L., Nasser, A., Ahmed, R., Basit, A., & Khan, T. M. (2026). Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression. Diabetes, Obesity and Metabolism, 28(6), 4901-4914. https://doi.org/10.1111/dom.70676

Vancouver

Tahir M, Meghani MA, Uddin MS, Talib A, Ahmad ZB, Khan AA, et al. Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression. Diabetes, Obesity and Metabolism. 2026;28(6):4901-4914. doi:10.1111/dom.70676

BibTeX
@article{Tahir2026,
  author = {Tahir, Muhammad and Meghani, Marium Ali and Uddin, Muhammad Salik and Talib, Abbeha and Ahmad, Zainab Binte and Khan, Ammaar Ali and Ahmed, Muhammad and Dinsmore, Lydia and Nasser, Abdul and Ahmed, Raheel and Basit, Abdul and Khan, Taimor Mohammed},
  title = {Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {6},
  pages = {4901--4914},
  doi = {10.1111/dom.70676}
}
Kostenlos starten →